Zobrazeno 1 - 7
of 7
pro vyhledávání: '"PengRong Lou"'
Publikováno v:
Medicina, Vol 59, Iss 8, p 1463 (2023)
Background and Objectives: Radiotherapy (RT) plays an important role in the treatment for locally advanced rectal cancer patients. It can bring radio exposure together with the survival benefit. Cancer survivors are generally at an increased risk for
Externí odkaz:
https://doaj.org/article/1fb0d27f358d4f62aadf5997c32b6220
Autor:
PeiYao Liu, XiaoShuang Niu, Dan Ou, JianJian Qiu, PengRong Lou, LiangJun Xue, Xin Zhou, Tingting Xu, XiaoShen Wang
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Purpose: Radiation-induced temporal lobe necrosis (TLN) was once regarded as a progressive and irreversible disease in the era of two-dimensional radiotherapy. However, in the era of intensity-modulated radiotherapy (IMRT), the long-term development
Externí odkaz:
https://doaj.org/article/fac9503c40964310a775bb369349eb7f
Publikováno v:
Current Radiopharmaceuticals. 16:50-56
Background: Myelosuppression is common and threatening during tumor treatment. However, the effect of radiation on bone marrow activity, especially leukocyte count, has been underestimated in cervical cancer. The aim of this study was to evaluate the
Chemotherapy-induced myelosuppression is common and threatening, however, the effect of radiation on bone marrow activity especially leukocyte count has been underestimated in cervical cancer. Pelvic radiation-related intestinal toxicity is prevalent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84206f025ea07c9a72240edd35b279d8
https://doi.org/10.21203/rs.3.rs-265849/v1
https://doi.org/10.21203/rs.3.rs-265849/v1
Publikováno v:
Molecular medicine reports. 20(4)
The E3 ubiquitin ligase RAD18 has been identified as an oncoprotein that exhibits prometastatic properties in various types of cancer; however, the role of RAD18 in cervical cancer (CC) remains unclear. In the present study, it was revealed that incr
Publikováno v:
Investigational new drugs. 37(2)
Purpose The current standard treatment for locally advanced nasopharyngeal carcinoma (LANPC) is intensity-modulated radiation therapy (IMRT) plus cisplatin concurrent chemoradiotherapy (CCRT). However, this regimen has well-known hematological and ga
Publikováno v:
Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences. 45(4)